Holds one active US DMF and 2 valid CEPs for docetaxel, filing since 2011. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 7 markets.
EDQM certificate database
FDA, List of Drug Master Files
Holds one active US DMF and 2 valid CEPs for docetaxel, filing since 2011. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 7 markets.
Holds one active US DMF and one valid CEP for docetaxel, filing since 2022. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for docetaxel, filing since 2010. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 8 markets.
Holds one active US DMF and one valid CEP for docetaxel, filing since 2022. Its 2019 FDA inspection closed as VAI.
Holds one active US DMF for docetaxel, filing since 2011. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one valid CEP for docetaxel, filing since 2025. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 valid CEPs for docetaxel, filing since 2022. Its GMP is recognised in 1 market.
Holds one active US DMF for docetaxel, filing since 2009.
Holds one active US DMF for docetaxel, filing since 2016.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Docetaxel manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free